| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |